Gastroenterology
From the Journals
Persistent abdominal pain: Not always IBS
The challenge of diagnosing and treating persistent abdominal pain can be tackled by greater awareness of the multiple potential causes of this...
From the Journals
Baclofen shows limited role in GERD
The drug showed benefit in PPI refractory symptoms for patients with non-acid reflux.
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for Crohn’s disease
Risankizumab is already approved in the United States for the treatment of adults with active psoriatic arthritis and moderate to severe plaque...
Conference Coverage
More evidence dementia not linked to PPI use in older people
Investigators assessed almost 19,000 older adults for use of PPI or H2RA medications and risk for incident dementia or cognitive decline over time...
Conference Coverage
Adsorbent offers promise for irritable bowel syndrome diarrhea
First developed 30 years ago in Eastern Europe, PMSPH is marketed over the counter in 30 European countries under the name Enterosgel.
Conference Coverage
Bacterial cocktail, spores counter recurrent C. diff
Both the complex mixture and specific, refined spores may hold promise in reducing recurrences, and may circumvent fecal microbiota transplants....
Conference Coverage
Treatment for alcohol abuse reduces hepatitis readmission
However, these support systems are not always feasible or easy to introduce.
Conference Coverage
AUA 2022: A report from the trenches
Hundreds of talks and abstracts were presented over the 4 days in New Orleans.
Conference Coverage
Gallstone disease may be a harbinger of pancreatic cancer
“If you have a patient who presents with gallstone disease and they have other symptoms, you should not necessarily attribute those symptoms just...
Latest News
Ondansetron use for acute gastroenteritis in children accelerates
Cross-sectional analysis shows steady increase in ondansetron use but no decrease in intravenous rehydration or hospitalizations.
Conference Coverage
IBD after age 60: More evidence antibiotics play a role
IBD “should be considered, especially if you have a patient who’s reporting multiple courses of antibiotics in the last few years.”